Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-03-08 @ 11:03 PM
Study NCT ID:
NCT04324151
Status:
RECRUITING
Last Update Posted:
2024-09-19
First Post:
2020-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC
Sponsor:
Organization: